Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-02

Clinical Trial Update: Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for realSKIN as an alternative to autografting in burn wounds; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • realSKIN

Snippet

Sponsor: XenoTherapeutics, Inc. | Conditions: Burns Degree Third, Burn (Disorder) | Phase 3 | Status: RECRUITING